Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
May 6, 2016
Document Date
May 6, 2016
Form Description
Form of prospectus disclosing information facts events covered in both forms 424B1 424B3
Filing Group
Registration Statements
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.